{
    "title": "114_hr3284",
    "content": "The Act titled \"Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015\" establishes a patient registry for mesothelioma data collection and research under Title III of the Public Health Service Act. The Secretary will develop a patient registry to collect data on mesothelioma in the US, including incidence and prevalence. The registry will be used to track epidemiology, collect health information, and enhance activities for mesothelioma patients. The patient registry for mesothelioma will collect data to improve treatment outcomes, describe incidence and prevalence, facilitate research, examine associated factors, and outline key demographic factors. The patient registry for mesothelioma aims to collect and store information on the incidence, prevalence, and associated factors of the disease in the United States. The registry also intends to make non-identifiable information available to the public to support research, prevention, and treatment efforts for mesothelioma. The patient registry for mesothelioma aims to collect and store information on demographics, risk factors, diagnosis, and progression markers associated with the disease. It may also include relevant information for analysis on mesothelioma. The patient registry for mesothelioma aims to collect information on epidemiology, natural history, prevention, detection, management, treatment approaches, and outcomes measures. The Secretary consults with experts in epidemiology and disease surveillance. The Secretary consults with experts in epidemiology, disease surveillance, national associations focusing on mesothelioma, health information technology specialists, clinicians specializing in mesothelioma, and research scientists conducting translational research. Coordination with other federal agencies is also emphasized. The Secretary will share registry information with federal agencies like NIH, FDA, CMS, AHRQ, VA, and DoD. Information from the registry will be made available to the public, including researchers, while ensuring privacy protection. The Secretary will ensure stringent privacy and security protections for the mesothelioma patient registry, in line with HIPAA laws. A report outlining findings from the registry must be submitted to Congress within 18 months of the Act's enactment. The Secretary will submit a report on the mesothelioma patient registry, including future expansion plans, scope, and partnerships with research communities. A subsequent report is due within 4 years of the Act's enactment. The Secretary will submit a report to Congress on the implementation of the Patient Registry Act of 2015, detailing the development and maintenance of the mesothelioma patient registry, the type of information collected, its use and availability, and the coordination of databases storing mesothelioma information."
}